Augustine R, Gezek M, Nikolopoulos V, Buck P, Bostanci N, Camci-Unal G
Stem Cell Rev Rep. 2024; 20(7):1692-1731.
PMID: 39028416
DOI: 10.1007/s12015-024-10738-y.
Matsuo S, Yokoi A, Yoshida K, Kitagawa M, Asano-Inami E, Miura M
J Extracell Biol. 2024; 3(6):e160.
PMID: 38947173
PMC: 11212330.
DOI: 10.1002/jex2.160.
Iordache F, Petcu A, Pisoschi A, Stanca L, Geicu O, Bilteanu L
Int J Mol Sci. 2024; 25(1).
PMID: 38203477
PMC: 10779355.
DOI: 10.3390/ijms25010302.
Liu N, Cheng Y, Wang D, Guan H, Chen D, Zeng J
Hum Cell. 2023; 37(2):408-419.
PMID: 38085460
PMC: 10891244.
DOI: 10.1007/s13577-023-01008-z.
Yaja K, Aungsuchawan S, Narakornsak S, Pothacharoen P, Pantan R, Tancharoen W
Heliyon. 2023; 9(8):e18599.
PMID: 37576189
PMC: 10413082.
DOI: 10.1016/j.heliyon.2023.e18599.
scRNA-Seq of Cultured Human Amniotic Fluid from Fetuses with Spina Bifida Reveals the Origin and Heterogeneity of the Cellular Content.
Dasargyri A, Gonzalez Rodriguez D, Rehrauer H, Reichmann E, Biedermann T, Moehrlen U
Cells. 2023; 12(12).
PMID: 37371048
PMC: 10296558.
DOI: 10.3390/cells12121577.
Development of a new treatment for preterm birth complications using amniotic fluid stem cell therapy.
Abe Y, Sato Y, Tanaka M, Ochiai D
Histol Histopathol. 2023; 38(9):965-974.
PMID: 36971371
DOI: 10.14670/HH-18-607.
Effect of the Enrichment in c-Kit Stem Cell Potential of Foetal Human Amniotic Fluid Cells: Characterization from Single Cell Analysis to the Secretome Content.
Casciaro F, Beretti F, Gatti M, Persico G, Bertucci E, Giorgio M
Biomedicines. 2023; 11(2).
PMID: 36830966
PMC: 9953071.
DOI: 10.3390/biomedicines11020430.
Amniotic fluid characteristics and its application in stem cell therapy: A review.
Shamsnajafabadi H, Soheili Z
Int J Reprod Biomed. 2022; 20(8):627-643.
PMID: 36313262
PMC: 9596929.
DOI: 10.18502/ijrm.v20i8.11752.
Stem Cell-Induced Cell Motility: A Removable Obstacle on the Way to Safe Therapies?.
Rosner M, Hengstschlager M
Stem Cells Transl Med. 2022; 11(1):26-34.
PMID: 35641164
PMC: 8895487.
DOI: 10.1093/stcltm/szab003.
Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities.
Fu Y, Ji J, Shan F, Li J, Hu R
Stem Cell Res Ther. 2021; 12(1):161.
PMID: 33658073
PMC: 7931610.
DOI: 10.1186/s13287-021-02212-0.
Recent Advances in Scaffolding from Natural-Based Polymers for Volumetric Muscle Injury.
Nuge T, Liu Z, Liu X, Ang B, Andriyana A, Simon Cornelis Metselaar H
Molecules. 2021; 26(3).
PMID: 33572728
PMC: 7865392.
DOI: 10.3390/molecules26030699.
Differentiation of cardiomyocyte-like cells from human amniotic fluid mesenchymal stem cells by combined induction with human platelet lysate and 5-azacytidine.
Markmee R, Aungsuchawan S, Tancharoen W, Narakornsak S, Pothacharoen P
Heliyon. 2020; 6(9):e04844.
PMID: 32995593
PMC: 7502343.
DOI: 10.1016/j.heliyon.2020.e04844.
Decellularized Extracellular Matrices and Cardiac Differentiation: Study on Human Amniotic Fluid-Stem Cells.
Gaggi G, Di Credico A, Izzicupo P, Sancilio S, Di Mauro M, Iannetti G
Int J Mol Sci. 2020; 21(17).
PMID: 32878275
PMC: 7504221.
DOI: 10.3390/ijms21176317.
Prophylactic therapy with human amniotic fluid stem cells improved survival in a rat model of lipopolysaccharide-induced neonatal sepsis through immunomodulation via aggregates with peritoneal macrophages.
Sato Y, Ochiai D, Abe Y, Masuda H, Fukutake M, Ikenoue S
Stem Cell Res Ther. 2020; 11(1):300.
PMID: 32690106
PMC: 7370504.
DOI: 10.1186/s13287-020-01809-1.
Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress-Related Neurodegeneration.
Angeloni C, Gatti M, Prata C, Hrelia S, Maraldi T
Int J Mol Sci. 2020; 21(9).
PMID: 32392722
PMC: 7246730.
DOI: 10.3390/ijms21093299.
Different culture method changing CD105 expression in amniotic fluid MSCs without affecting differentiation ability or immune function.
Wang D, Liu N, Xie Y, Song B, Kong S, Sun X
J Cell Mol Med. 2020; 24(7):4212-4222.
PMID: 32119193
PMC: 7171344.
DOI: 10.1111/jcmm.15081.
Multipotency of mouse trophoblast stem cells.
Hou M, Han J, Li G, Kwon M, Jiang J, Emani S
Stem Cell Res Ther. 2020; 11(1):55.
PMID: 32054514
PMC: 7020558.
DOI: 10.1186/s13287-020-1567-4.
Human amniotic fluid stem cells attract osteoprogenitor cells in bone healing.
Basile M, Marchegiani F, Novak S, Kalajzic I, Di Pietro R
J Cell Physiol. 2019; 235(5):4643-4654.
PMID: 31650536
PMC: 7018542.
DOI: 10.1002/jcp.29342.
In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion.
Abe Y, Ochiai D, Masuda H, Sato Y, Otani T, Fukutake M
Stem Cells Transl Med. 2019; 8(11):1170-1179.
PMID: 31407874
PMC: 6811697.
DOI: 10.1002/sctm.19-0002.